PICX CAR-T therapy
/ Chongqing Precision Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 21, 2026
In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=15 | Recruiting | Sponsor: Chongqing Precision Biotech Co., Ltd
New P1 trial • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 1
Of
1
Go to page
1